Visna virus is a pathogenic lentivirus of sheep that is distantly related to the primate lentiviruses, including human immunodeficiency virus type 1. The visna virus genome encodes a small regulatory protein, Tat, which is necessary for efficient viral replication and enhanced viral transcription. To investigate the mechanism of action of the visna Tat protein and to localize the protein domain(s) responsible for transcriptional activation, chimeric proteins containing visna virus Tat sequences fused to the DNA binding domain of the yeast transactivation factor GALA (residues 1 to 147) were made. The GALA-Tat fusion proteins were transfected into cells and tested for the ability to activate the adenovirus Elb promoter via upstream GALA DNA binding sites. Full-length GALA-Tat fusion proteins were weak transactivators in this system, giving only a two-to fourfold increase in transcription in several cell types, including HeLa and sheep choroid plexus cells. In contrast, fusion of the N-terminal region of the Tat protein to GALA revealed a potent activation domain. Amino acids 13 to 38 appeared to be the most critical for activation. No other region of the protein showed any activation in the GAL4 system. This N-terminal region of the visna virus Tat protein has a large number of acidic and hydrophobic residues, suggesting that Tat has an acidic activation domain common to many transcriptional transactivators. Mutations in hydrophobic and bulky aromatic residues dramatically reduced the activity of the chimeric protein. Competition experiments suggest that mechanism of the visna virus Tat activation domain may closely resemble that of the herpesvirus activator VP16 and human immunodeficiency virus Tat, a related lentivirus activator, since both significantly reduce the level of visna virus Tat activation.
Lentiviruses are a subfamily of nononcogenic retroviruses that cause chronic, multiorgan diseases characterized by long incubation periods and slowly progressive clinical courses. Visna virus causes interstitial pneumonitis and a progressive inflammatory disease of the central nervous system (54) . One important biologic property common to all lentiviruses is a tropism for cells of the monocyte/macrophage lineage during natural infection. (21) . Infected monocytes, however, do not exhibit significant levels of viral RNA or protein synthesis until these cells mature into macrophages (20, 21, 54) . This maturation process can be stimulated by treating monocytes with agents such as phorbol esters or cytokines and is related to the activation of specific cellular transcription factors (1, 2, 8, 11, 16, 37, 60) .
Gene expression directed by the visna virus long terminal repeat (LTR) is also induced upon activation of monocytes to macrophages (17, 67) . Studies done in this laboratory have identified sequences in the U3 region of the visna virus LTR important for transcriptional activity. These include a TATA box at -20 and a recognition site for the AP-4 transcription factor at -60 (53) . In addition, there are multiple AP-1 sites in the viral LTR, and the one most proximal to the TATA box mediates viral activation by phorbol ester in macrophages (17) .
This AP-1 site has a sequence identical to the AP-1 consensus and appears to be critical for efficient transcription (39, 61, 62) . Previous studies have shown that the Jun and Fos proteins bind Transactivators contain at least two essential domains; one directs the protein to its target promoter through direct DNA binding or protein-protein interactions, and a second facilitates events that increase initiation of RNA transcription presumably through direct contact with other cellular factors at the promoter (57, 58) . Previous studies in our laboratory have not detected direct binding of visna virus Tat to the visna virus LTR or to nascent RNA transcripts (19b) . Therefore, the visna virus Tat protein may be involved in an indirect activation mechanism, possibly by recruiting or modulating cellular factors involved in the initiation of transcription.
To further study the mechanism of visna virus Tat transactivation, we identified the Tat activation domain and essential amino acid residues within it by using a GALA-Tat chimera system. Results showed that Tat has a single, potent acidic activation domain. Tat has a pattern of bulky aromatic and hydrophobic residues which are important for its activity. Although, the activation domain is constitutively active when linked to GAL4, its activity is influenced by intramolecular mechanisms in the context of full-length Tat. A leucine-rich region adjacent to the N-terminal activation domain (residues 39 to 53) was found to dramatically reduce Tat transactivation. Further, competition experiments using the visna virus Tat activation domain with VP16, an acidic activator, and the HIV Tat, an unclassified activator with an acidic region, suggest that although the targeting regions of these activators may be different, all three may act through a common set of recruiting factors, resulting in activated transcription.
MATERUILS AND METHODS
Plasmid constructions. The effector plasmid pGH250 and the target plasmids Elb-CAT, (GAL4)1Elb-CAT, and (GAL4)5Elb-CAT were obtained from Gary Hayward and previously described by Hardwick et al. (26) . Constructs containing chimeric genes of GAL4-Tat were generated by cloning BglII (5' end)-and XbaI (3' end)-digested PCR products of Tat into the BglII and XbaI sites of the GAL4 DNA binding domain in GH250. Sequences of the oligonucleotides synthesized for the generation of these constructs are shown in Table   1 . Mutated primers (Table 1) were used to generate single amino acid changes shown in Fig. 4 and 7 .
The SV2VP16 construct contains the entire VP16 open reading frame driven by the simian virus 40 (SV40) promoter as described previously (26) . The HIV Tat Designer Gene construct was obtained from the NIAID AIDS Research and Reference Reagent Program (Ogden BioServices Corp.). The HIV-1 Tat gene was subcloned into the pSVL expression vector by using PCR to generate an XhoI site (5') and a BamHI site (3'). Sequences of the oligonucleotides designed for cloning of Tat into the pSVL expression vector are shown in Table 1 . All new constructs were sequenced to verify reading frames and mutations.
Transfections. HeLa and sheep choroid plexus cells were maintained in modified Eagle medium supplemented with 10% fetal bovine serum and incubated at 5% CO2 at 37°C. Cells were transfected by the calcium phosphate method as previously described (26) . Briefly, HeLa cells were seeded into six-well cluster dishes at a density of 4 x 105 cells per well 24 h prior to transfection. The cells were given fresh medium 4 h before transfection. The transfection mix contained 1 ,ug of target and 2 ,ug of effector plasmid, 125 ,ul of 2x HEPES (N-2-hydroxyethyl-piperazine-N'-2-ethanesulfonic acid)-buffered saline (274 mM NaCl, 10 (12) . The N-terminal portion of the protein (domain I) contained a potent activation domain with a 594-fold increase in activity over the control (Fig. 2a, lane 3) . Initial experiments showed that constructs containing the activation domain had activity that was out of the linear range of the CAT assay. Therefore, in subsequent experiments, lysates were diluted either 1:10 or 1:50 to give results within the linear range (dilutions are indicated in Fig. 2 ). The activity of the N terminus was shown to be due to a specific interaction between the chimeric proteins and the GAL4 binding sites, as a construct containing no GAL4 binding sites was not responsive to the GAL4-Tat fusion proteins (Fig. 2b) . Domains II and III of Tat do not have activity, suggesting that the Tat protein contains a single activation domain (Fig. 2a, lanes 4 and 5) Fig. 2c show that the full-length Tat protein had essentially no activity, while the N-terminal portion of the protein contained the activation domain and had a 28-fold increase over GAL4 alone. The fold activation in these cells is notably lower than in HeLa cells. This difference is thought to be due to a lower efficiency of expression resulting from the difficulty in transfecting this primary cell type. These results indicate that the activation domain of Tat does not appear to be cell type specific, although this does not rule out the possibility that it is a stronger activator in certain cell types, depending on the cellular factors important for its activity.
Determination of the boundaries of the activation domain.
To define a C-terminal boundary for the activation domain, a series of deletions was made in domain I from amino acid 43. Interestingly, the activity of the Tat protein increased 60% when amino acids 39 to 43 were removed [Tat(13-38); Fig. 3 ]. Further deletion of amino acids 30 to 38 [compare Tat with Tat(13-29)] decreased activity almost threefold. Therefore, it appears that residues between 30 and 38 are important for transactivation.
To localize the amino acids that comprise the minimal activation domain, N-terminal deletions were also made in domain I (Fig. 3) . Removal of the first 12 amino acids of Tat increased its ability to transactivate almost 2-fold (1,226-fold versus 613-fold). Further N-terminal deletions in Tat demonstrated that residues between amino acids 13 and 19 were critical for transactivation, as the Tat(19-38) construct had a fourfold decrease in activity (Fig. 3) . Finally, the Tat(25-38) construct had no activity, indicating that critical residues and/or structure had been lost by deletion of amino acids 19 to 25. The results in Fig. 3 clearly demonstrate that Tat has a potent activation domain between residues 13 and 38. The minimal activation domain lies between amino acids 19 and 29. It is difficult to discern from these experiments whether critical residues had been deleted in Tat (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) or whether the protein was simply reduced to a nonfunctional size. However, mutational analysis described below supports the former theory, that critical residues had been lost.
Hydrophobic and aromatic residues are important for the acidic activation domain of Tat. Examination of the N-terminal amino acid sequence of Tat revealed a characteristic acidic domain, common to many other viral transcriptional transactivators (26, 46, 65) . Recent reports have suggested, however, that it is not the acidic residues which are critical for function (10 residues may be more important in defining the activation domain. Cress and Triezenberg (10) reported that in the case of VP16, bulky hydrophobic residues in the VP16 acidic activation domain are critical for activator function. This pattern of important hydrophobic residues was not limited to acidic activators and was also found in the glutamine-rich activator Spl (10) . Figure 4 is an alignment of several known viral transactivators with conserved hydrophobic and aromatic residues in a characteristic pattern such that when mutated, the activity of the domain is diminished (10, 26, 46) . Hydrophobic residues of visna virus Tat can be aligned at least two different ways with VP16 and Rta (Fig. 4) . Point mutations made in this region are shown in Fig. 5 (63) . Tat has two Phe residues in the region from amino acids 19 to 25 of the activation domain. Mutation of both of these residues resulted in the most dramatic loss of activity compared with other mutations in the valine residues (Fig. 5) . This finding indicates that in visna virus Tat, the bulky aromatic residues are critical for the function of the activation domain. However, it is not yet clear if their spatial arrangement is critical.
Competition of Tat activation by VP16 and HIV Tat. The data thus far have shown that the activation domain of visna virus Tat shares some important characteristics with VP16. First, both Tat and VP16 have a high content of acidic and hydrophobic residues in their activation domains. Second, Tat has hydrophobic residues in a characteristic pattern, similar to VP16, which may play a role in the secondary structure of these activators. Finally, Phe residues within the activation domains of both proteins are critical for activity. To determine if these two activators utilize similar cellular factors, competition assays were performed to determine if an SV40-driven VP16 construct containing the entire coding region could inhibit the activity of a GAL4-Tat chimera. An SV40 HIV-Tat construct containing the entire protein was also used in these experiments as a control for a nonacidic activator. The results in Fig. 6 show that VP16 did, in fact, inhibit the activity of GAL4-Tat(13-38) and caused a more than five-to sixfold decrease in activation. Somewhat surprisingly, HIV Tat was also effective as a competitor, although this effect is probably due to the TAR-independent activation capacity of HIV Tat, since there is no TAR element present in this system. pSV2Neo was used as a control for squelching in these experiments and did not compete with visna virus Tat.
Identification of an inhibitory domain. Initial experiments (Fig. 2) 
Comparison of amino acid sequences of viral activation domains. Hydrophobic residues (boxed) of several herpesvirus activators and visna virus Tat are aligned. Alignment of viral and cellular sequences has been previously described (10, 26, 46 Fig. 2 resulted in a 1.5-fold increase in activity. These results suggested that the region of repression was located between residues 39 and 53. This region of the Tat protein contains a high content of leucine residues that are conserved not only between visna virus strains but also in the Tat protein of caprine arthritis encephalitis virus, a closely related lentivirus. These leucines do not form a typical leucine zipper (38) , characteristic of many transactivators in the bZIP family. However, it has been recently reported that leucine residues (not necessarily forming a leucine zipper) may be involved in protein-protein interactions in other transcriptional activators (15) .
To determine if the leucines in this region were, in fact, responsible for the inhibitory activity of the Tat analysis of the activation domain showed tI 19 and 21 are important for activity. It also hydrophobic residues may be important domain, as mutation of valine residues at reduces the activity of Tat (12, 55) . In most cases, however, the level of transactivation has been considered relatively low (10-to 40-fold), in part because of a high basal level of transcription of the viral LTR (12) . Therefore, it was not particularly surprising that activity of the full-length Tat was low in the GAL4 system (fourfold; Fig. 2a (5, 13, 14) . Experiments have shown that TAR is recognized as RNA rather than DNA and that HIV-1 Tat does, in fact, bind to the nascent mRNA (14) . It remains controversial whether the Tat protein binds TAR to recruit basal transcription factors and thus promote the formation of new initiation complexes, as is the function of most transactivators, or to aid in the processivity of the polymerase, allowing full-length transcripts to be made (5, 13, 14, 31, 34, 35, 49, 68) .
Indeed, HIV-1 Tat is unique among viral and cellular transactivators, which have been shown to work through a variety of strategies involved in binding to DNA consensus sites proximal to the TATA site and interacting with basal transcription factors to increase both the rate and amount of polymerase II initiation. TAR-like structures have not been identified in visna viruses or in caprine arthritis encephalitis virus. We propose that visna virus Tat, unlike HIV-1 Tat, acts more like other viral activators. These transactivator proteins, such as VP16 and ElA, have been shown to bind cellular factors which in turn bind to their DNA consensus sites. Recent studies have shown, however, that VP16 can bind to factors within the initiation complex itself, such as TBP and TFIIB (4, 23, 24, 44) . Recent studies by Ransone et al. (59) have suggested that Jun and Fos bind to TBP as well as their target AP-1 consensus site (59) . In the case of the herpesvirus Zta protein, it has been hypothesized that this activator may have originated from a cellular AP-1 family DNA-binding protein (43) . Its responsive element (ZRE) contains an AP-1 site, and Zta can bind as a dimer to this site (7) . Studies have shown that instead of the characteristic leucine zipper found in bZIP proteins, Zta has a region of repeated hydrophobic residues that can support its dimerization (15) . Interestingly, this domain can substitute for the leucine zipper of c-Fos (15 what the endogenous levels of Jun and Fos homologs are in the natural host cells of visna virus, the sheep monocyte/macrophage. It is possible that the activation of the sheep monocyte to a macrophage, which is necessary for visna virus activation, is also required to relieve repression by the inhibitory domain of Tat. This could occur by activation or upregulation of cellular factors, possibly Jun and Fos, required to bind to Tat and cause a conformational change to allow exposure of the activation domain. Clearly, the mechanism of activation is complex and has some redundancies built in to fulfill the requirements of cell specificity and distinct signal transduction pathways utilized within the cell under different conditions.
